 |
PatientsSleep apnea patients are diagnosed by their physicians and usually go through a sleep lab test. Treatment is then administered by sleep physicians and/or Ear Nose Throat (ENT) physicians. ImThera’s solution is designed for patients with moderate to severe obstructive sleep apnea (apnea-hypopnea index (AHI) of 15–45 and higher). The surgical procedure takes less than an hour to complete and typically requires a one-night hospital stay. Within a couple of weeks of the procedure, patients return for an overnight sleep test and a device calibration session. Therapy begins thereafter. The aura6000™ system is pending applications and clearances to market by the regulatory agencies. ImThera will be conducting European clinical trials starting Fall 2009. U.S. clinical trials are expected to begin in 2010. For more information, register using the box to the left. |
|